Common Stock, Shares, Outstanding of BridgeBio Pharma, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BridgeBio Pharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • BridgeBio Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 194,771,957, a 2.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 194,771,957 +4,727,484 +2.5% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 192,633,286 +3,646,739 +1.9% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 191,162,659 +3,129,921 +1.7% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 189,826,023 +2,703,279 +1.4% 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 190,044,473 +14,961,522 +8.5% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 188,986,547 +14,854,593 +8.5% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 188,032,738 +26,612,807 +16% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 187,122,744 +26,687,506 +17% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 175,082,951 +24,457,379 +16% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q3 2023 174,131,954 +24,764,867 +17% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 161,419,931 +13,176,734 +8.9% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 160,435,238 +12,746,845 +8.6% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 150,625,572 +3,282,249 +2.2% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 149,367,087 +2,279,196 +1.6% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 148,243,197 -1,371,543 -0.92% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 147,688,393 -1,426,207 -0.96% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 147,343,323 +24,493,934 +20% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 147,087,891 +24,545,481 +20% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 149,614,740 +27,363,482 +22% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 149,114,600 +27,754,745 +23% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 122,849,389 -808,898 -0.65% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 122,542,410 +5,182,908 +4.4% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 122,251,258 +122,251,258 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 121,359,855 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 123,658,287 +31,600,583 +34% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 117,359,502 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 0 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 92,057,704 31 Dec 2018 10-K 03 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.